Lineage Cell Therapeutics : Immediate Report -March 24, 2024

Lineage Cell Therapeutics : Immediate Report -March 24, 2024 at 04:37 am EDT

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
...

Related Keywords

New York , United States , Washington , California , City Of New York , American , Georgea Samuel , , Subsidiary Of The Company , Commission File Number , Lineage Cell Therapeutics Inc , Exchange Commission The , Governmental Authority , B Riley Securities Inc , Cantor Fitzgerald Co , Company The Prospectus , Exchange Commission , Warranties Of The Company , Placement Shares Of The Company , Company Or Lineage , Financial Industry Regulatory Authority Inc , Public Company Accounting Oversight Board United States , United States Drug Enforcement Administration , Securities Exchange , Termination Of Prior Offering Program , Consent Of Sheppard Mullin Richter Hampton , Opinion Of Sheppard Mullin Richter Hampton , Neither The Company , Sales Of The Company , Drug Administration , Sheppard Mullin Richter Hampton , Company To Cantor , Company Of The Placement , Public Accounting Firm , Securities Exchange Act , Cell Therapeutics , Its Charter , Principal Executive Offices , Zip Code , Telephone Number , Including Area Code , Former Name , Former Address , Changed Since Last Report , Securities Act , Exchange Act , Material Definitive , Lineage Cell Therapeutics , Sales Agent , Sales Agreement , Registration Statement , Under Rule , New Registration Statement , New Registration , Sheppard Mullin Richter , Controlled Equity Offering Sales Agreement , Cantor Fitzgerald , Prior Sales , Prior Sales Agreement , Investigational New Drug Application , Oligodendrocyte Progenitor Cells , Spinal Cord Injury , Novel Device , Annual Report , Page Interactive Data File , Regulations K , Corporate Secretary , Placement Shares , Common Shares , Prospectus Supplement , Securities Act Regulations , Issuer Free Writing Prospectus , Electronic Data Gathering Analysis , Interactive Data Electronic Application , Placement Notice , Business Days , Trading Day , Net Proceeds , Settlement Date , Depository Trust Company , Custodian System , Business Day , Maximum Amount , Applicable Time , Incorporated Documents , Issuer Free Writing Prospectuses , Xtensible Business Reporting Language , Regulations X , Material Adverse , Free Writing Prospectuses , Material Adverse Effect , Financial Industry Regulatory Authority , Current Report , Public Accounting , Public Company Accounting Oversight Board , Sarbanes Oxley Act , United States Food , Governmental Authorities , United States Federal Food , Cosmetic Act ,

© 2025 Vimarsana